Webinar: Advances in Precision Medicine in Lupus and Rheumatoid Arthritis
Precision medicine aspires to revolutionize healthcare by using novel biomarkers to individualize patient treatments and ensure that patients receive the most effective drugs the first time. This methodology aims to avoid the current trial-and-error approach to patient care. In this webinar, we review recent precision medicine studies in lupus and rheumatoid arthritis and discuss new advances in biomarker research for patient stratification.
Reader in Rheumatology
Myles Lewis is a Reader at Queen Mary University of London, where he leads a bioinformatics and wet lab team developing biomarkers for precision medicine in autoimmune diseases including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). He studied preclinical medicine at Cambridge University, clinical medicine at Oxford University and obtained his PhD during a Wellcome Trust Fellowship at Imperial College. He is involved in data analysis for several UK and EU stratified medicine consortia. He is also a clinician working as a consultant rheumatologist at Barts and The Royal London NHS Trust.
Date: Thursday, December 2, 2021
Time: 11:00am ET / 8:00am PT
Duration: 1 Hour
Now Available On-Demand